Use of Arsenic Trioxide as an Antivascular and Thermosensitizing Agent in Solid Tumors
Arsenic trioxide, As2O3 (ATO), has been found to be an effective chemotherapy drug for acute promyelocytic leukemia but its effect on solid tumors has not been fully explored. In the present report, we describe our observation that ATO is a potent antivascular agent and that it markedly enhances the...
Main Authors: | Robert J. Griffin, Sang H. Lee, Kelly L. Rood, Michael J. Stewart, John C. Lyons, Young S. Lew, Heonjoo Park, Chang W. Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2000-01-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558600800469 |
Similar Items
-
Treatment of new cases of Acute Promyelocytic Leukemia With Arsenic Trioxide
by: Ardeshir Ghavamzadeh, et al.
Published: (2005-03-01) -
Arsenic Trioxide: Pharmacological Applications
by: German Madrigal Redondo, et al.
Published: (2023-04-01) -
A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
by: Kamran Alimoghaddam
Published: (2014-09-01) -
Arsenic trioxide for acute promyelocytic leukemia in a patient on chronic hemodialysis
by: Jose Tinajero, et al.
Published: (2022-01-01) -
Hesperidin attenuates arsenic trioxide-induced cardiac toxicity in rats
by: Gayatri Khuntia, et al.
Published: (2023-01-01)